Activation of PPARγ attenuates LPS-induced acute lung injury by inhibition of HMGB1-RAGE levels

European Journal of Pharmacology

Volumn 726, Issue 1, 2014, Pages 27-32

  Wang, Guizuo ^a   Liu, Lu ^a   Zhang, Yonghong ^a   Han, Dong ^a   Lu, Jiamei ^a   Xu, Jing ^a   Xie, Xinming ^a   Wu, Yuanyuan ^a   Zhang, Dexin ^a   Ke, Rui ^a   Li, Shaojun ^a   Zhu, Yanting ^a   Feng, Wei ^a   Li, Manxiang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

ALI; HMGB1; PPAR ; RAGE

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN RECEPTOR; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ACUTE LUNG INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; METABOLISM; MOUSE;

ACUTE LUNG INJURY; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; HMGB1 PROTEIN; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PPAR GAMMA; RECEPTORS, IMMUNOLOGIC; THIAZOLIDINEDIONES;

EID: 84893202902     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.01.030     Document Type: Article

References (38)

1. D.C. Angus, L. Yang, L. Kong, J.A. Kellum, R.L. Delude, K.J. Tracey, and L. Weissfeld Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis Crit. Care Med. 35 2007 1061 1067 (Pubitemid 46598956)
2. Y. Aoki, T. Maeno, K. Aoyagi, M. Ueno, F. Aoki, N. Aoki, J. Nakagawa, Y. Sando, Y. Shimizu, T. Suga, M. Arai, and M. Kurabayashi Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis Respir.; Int. Rev. Thorac. Dis. 77 2009 311 319
3. M. Belvisi, and D. Hele Peroxisome proliferator-activated receptors as novel targets in lung disease Chest 134 2008 152 157 (Pubitemid 352008777)
4. B.C. Creagh-Brown, G.J. Quinlan, T.W. Evans, and A. Burke-Gaffney The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target? Intensive Care Med. 36 2010 1644 1656
5. L. Cross, and M. Matthay Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury Crit. Care Clin. 27 2011 355 377
6. C. Dinarello Anti-inflammatory agents: present and future Cell 140 2010 935 950
7. A.M. El-Asrar, L. Missotten, and K. Geboes Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes Mol. Vis. 17 2011 508 518
8. L. Feng, M. Zhu, M. Zhang, X. Jia, X. Cheng, S. Ding, and Q. Zhu Amelioration of compound 4,4'-diphenylmethane-bis(methyl)carbamate on high mobility group box1-mediated inflammation and oxidant stress responses in human umbilical vein endothelial cells via RAGE/ERK1/2/NF-kappaB pathway Int. Immunopharmacol. 15 2013 206 216
9. A. Frank, and B. Thompson Pharmacological treatments for acute respiratory distress syndrome Curr. Opin. Crit. Care 16 2010 62 68
10. M. Gao, Z. Hu, Y. Zheng, Y. Zeng, X. Shen, D. Zhong, and F. He Peroxisome proliferator-activated receptor gamma agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor kappaB and activator protein 1 Shock 36 2011 228 234
11. X.Q. Gao, H.W. Li, X. Ling, Y.H. Qiu, Y. Gao, and Y. Zhang Effect of rosiglitazone on rabbit model of myocardial ischemia-reperfusion injury Asian Pac. J. Trop. Med. 6 2013 228 231
12. R.S. Goldstein, M. Gallowitsch-Puerta, L. Yang, M. Rosas-Ballina, J.M. Huston, C.J. Czura, D.C. Lee, M.F. Ward, A.N. Bruchfeld, H. Wang, M.L. Lesser, A.L. Church, A.H. Litroff, A.E. Sama, and K.J. Tracey Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia Shock 25 2006 571 574 (Pubitemid 44297016)
13. Q. Gong, J.F. Xu, H. Yin, S.F. Liu, L.H. Duan, and Z.L. Bian Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice Scand. J. Immunol. 69 2009 29 35
14. T. Haraguchi, K. Takasaki, T. Naito, K. Hayakawa, S. Katsurabayashi, K. Mishima, K. Iwasaki, and M. Fujiwara Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism Neurosci. Lett. 464 2009 151 155
15. Q. He, H. You, X.M. Li, T.H. Liu, P. Wang, and B.E. Wang HMGB1 promotes the synthesis of pro-IL-1beta and pro-IL-18 by activation of p38 MAPK and NF-kappaB through receptors for advanced glycation end-products in macrophages Asian Pac. J. Cancer Prev.: APJCP 13 2012 1365 1370
16. W. Huang, Y. Liu, L. Li, R. Zhang, W. Liu, J. Wu, E. Mao, and Y. Tang HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways Inflammation 35 2012 350 362
17. J. Jin, J. Albertz, Z. Guo, Q. Peng, G. Rudow, J.C. Troncoso, C.A. Ross, and W. Duan Neuroprotective effects of PPAR-gamma agonist rosiglitazone in N171-82Q mouse model of Huntington's disease J. Neurochem. 125 2013 410 419
18. E.R. Johnson, and M.A. Matthay Acute lung injury: epidemiology, pathogenesis, and treatment J. Aerosol Med. Pulm. Drug Deliv. 23 2010 243 252
19. K.A. Kirkby, and C.A. Adin Products of heme oxygenase and their potential therapeutic applications Am. J. Physiol. - Ren. Physiol. 290 2006 F563 571
20. T. Kohno, T. Anzai, K. Naito, T. Miyasho, M. Okamoto, H. Yokota, S. Yamada, Y. Maekawa, T. Takahashi, T. Yoshikawa, A. Ishizaka, and S. Ogawa Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling Cardiovasc. Res 81 2009 565 573
21. G. Kronke, A. Kadl, E. Ikonomu, S. Bluml, A. Furnkranz, I.J. Sarembock, V.N. Bochkov, M. Exner, B.R. Binder, and N. Leitinger Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors Arterioscler. Thromb. Vasc. Biol. 27 2007 1276 1282 (Pubitemid 46809415)
22. M. Li, Z. Li, X. Sun, L. Yang, P. Fang, Y. Liu, W. Li, J. Xu, J. Lu, M. Xie, and D. Zhang Heme oxygenase-1/p21WAF1 mediates peroxisome proliferator-activated receptor-gamma signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells FEBS J. 277 2010 1543 1550
23. Z.G. Luan, H. Zhang, P.T. Yang, X.C. Ma, C. Zhang, and R.X. Guo HMGB1 activates nuclear factor-kappaB signaling by RAGE and increases the production of TNF-alpha in human umbilical vein endothelial cells Immunobiology 215 2010 956 962
24. G.E. Mullins, J. Sunden-Cullberg, A.S. Johansson, A. Rouhiainen, H. Erlandsson-Harris, H. Yang, K.J. Tracey, H. Rauvala, J. Palmblad, J. Andersson, and C.J. Treutiger Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1 Scand. J. Immunol. 60 2004 566 573 (Pubitemid 39665101)
25. T. Nakamura, N. Fujiwara, E. Sato, Y. Kawagoe, Y. Ueda, S. Yamada, and H. Koide Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome ASAIO J. 55 2009 395 399
26. S.E. Nissen, and K. Wolski Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N. Engl. J. Med. 356 2007 2457 2471 (Pubitemid 46919772)
27. D.S. Pisetsky, H. Erlandsson-Harris, and U. Andersson High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease Arthritis Res. Ther. 10 2008 209
28. G.P. Sims, D.C. Rowe, S.T. Rietdijk, R. Herbst, and A.J. Coyle HMGB1 and RAGE in inflammation and cancer Ann. Rev. Immunol. 28 2010 367 388
29. B. Starcher, and I. Williams A method for intratracheal instillation of endotoxin into the lungs of mice Lab Anim. 23 1989 234 240
30. J. Sunden-Cullberg, A. Norrby-Teglund, A. Rouhiainen, H. Rauvala, G. Herman, K.J. Tracey, M.L. Lee, J. Andersson, L. Tokics, and C.J. Treutiger Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock Crit. Care Med. 33 2005 564 573 (Pubitemid 40365558)
31. H. Ueno, T. Matsuda, S. Hashimoto, F. Amaya, Y. Kitamura, M. Tanaka, A. Kobayashi, I. Maruyama, S. Yamada, N. Hasegawa, J. Soejima, H. Koh, and A. Ishizaka Contributions of high mobility group box protein in experimental and clinical acute lung injury Am. J. Respir. Crit. Care Med. 170 2004 1310 1316 (Pubitemid 39657195)
32. V. Urbonaviciute, B.G. Furnrohr, C. Weber, M. Haslbeck, S. Wilhelm, M. Herrmann, and R.E. Voll Factors masking HMGB1 in human serum and plasma J. Leukoc. Biol. 81 2007 67 74 (Pubitemid 46021254)
33. L. Vande Walle, T.D. Kanneganti, and M. Lamkanfi HMGB1 release by inflammasomes Virulence 2 2011 162 165
34. H. Wang, O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K.R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P.E. Molina, N.N. Abumrad, A. Sama, and K.J. Tracey HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251 (Pubitemid 29329996)
35. C.C. Yeh, C.C. Lin, S.D. Wang, Y.S. Chen, B.H. Su, and S.T. Kao Protective and anti-inflammatory effect of a traditional Chinese medicine, Xia-Bai-San, by modulating lung local cytokine in a murine model of acute lung injury Int. Immunopharmacol. 6 2006 1506 1514
36. Y. Zhou, Y.Q. Jiang, W.X. Wang, Z.X. Zhou, Y.G. Wang, L. Yang, and Y.L. Ji HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage Hum. Immunol. 73 2012 1171 1174
37. J.R. van Beijnum, W.A. Buurman, and A.W. Griffioen Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1) Angiogenesis 11 2008 91 99
38. M.A. van Zoelen, H. Yang, S. Florquin, J.C. Meijers, S. Akira, B. Arnold, P.P. Nawroth, A. Bierhaus, K.J. Tracey, and T. van der Poll Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo Shock 31 2009 280 284